Herpes Virus Shows Promise in Treating Advanced Skin Cancer
TL;DR
Scientists have developed a genetically modified herpes simplex virus, RP1, which has shown promise in shrinking advanced melanoma tumors, including those deep inside the body, in a phase 1/2 clinical trial. The therapy, especially when combined with the immune drug nivolumab, has demonstrated significant tumor reduction in a substantial portion of patients, offering hope for more effective treatment options for melanoma, particularly in cases resistant to current therapies.
- Modified Herpes Virus Found to Shrink Deadly Skin Cancers in Clinical Trial ScienceAlert
- Herpes Virus Could Help Treat Advanced Cancer Newsweek
- Herpes virus could soon be approved to treat severe skin cancer New Scientist
- RP1 Plus Nivolumab Shows Durable Response in Advanced Melanoma Inside Precision Medicine
- Herpes virus could be a new way to treat skin cancer Mezha.Media
Want the full story? Read the original reporting
Read on ScienceAlert